Adma Biologics, Inc.
ADMA· Nasdaq
Released May 6, 2020, after the close
10-Q filed May 6, 2020, 36 days after period end · 0001193805-20-000562
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $10.20M | $3.53M | $4.04M | $2.63M |
| Net Income | -$19.25M | -$13.07M | -$17.82M | -$6.54M |
| EPS Diluted |
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
| -$0.26 |
| -$0.28 |
| -$0.39 |
| -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.